JHX changes
Pick any two versions below to diff them.
- Price
- $25.82 → $27.24(+5.5%)
- Discount category
- Below intrinsic value → Close to intrinsic value
- Next earnings
- Nov 6, 2026 → Nov 5, 2026
- Next earnings is estimate
- Yes → No
- Checkpoints
- Nov removed: 6, 2026 (estimate): added: 5, 2026: Q2 fiscal 2027 results: organic growth and free cash flow. Pending. Watch: Net sales of $1.485 billion to $1.575 billion, adjusted EBITDA of $420 million to $455 million and continued organic growth in fiber cement pass; results below guidance or a cut to the fiscal 2027 outlook fail. Sep 30, 2027: Net leverage below 2.0 times. Pending. Watch: Net leverage below 2.0 times at the end of Q2 fiscal 2028 passes; leverage above the target fails. 2027 (estimate): Closing of the Fermacell sale to Holcim. Pending. Watch: The sale closes for €840 million and about $600 million goes to debt repayment; a delay or a lower price fails.